EIQ.AX is trading 4.3% up today at $1.71 as investors reassess the strategic benefits of its recently completed A$110 million institutional placement.
- The capital raise was priced at A$1.45 per share, representing an 8.8% discount to the previous close, which initially pressured the stock during the July 1 session.
- Proceeds from the placement are earmarked to fund aggressive US market expansion and the development of AI-driven cardiovascular initiatives.
- The share price has successfully recovered above the placement level, signaling renewed market confidence in the company's long-term growth trajectory.